Maliar Tibor, Jedinák Andrej, Kadrabová Jana, Sturdík Ernest
Department of Biotechnology, University of Saint Cyril and Methodius, J Herdu 2, Trnava, 91701, Slovakia.
Eur J Med Chem. 2004 Mar;39(3):241-8. doi: 10.1016/j.ejmech.2003.12.003.
In the search for new proteinase inhibitors we have focused on the screening and Computer Assisted Drug Design (CADD) studies of polyphenolic compounds. In this paper we report CADD of flavonoles and flavones as trypsin inhibitors concomitant by the screening results. 5,7-Dihydroxy flavonoid have been found to be a perspective trypsin/trypsin-like-enzyme inhibitor. Flavanones and isoflavones are less effective trypsin inhibitors due to a lost of the optimal geometry leading to hydrogen bond interactions. Four different interaction modes were observed, flavonoids are stabilised in S(1) region of beta-trypsin by formation of two (apigenin) or at least one hydrogen bond and other significant electrostatic interactions. Quercetin, myricetin and morin have shown to be the best trypsin inhibitors tested. In general, flavonoids with suitably located hydroxy groups and planar conformation are the building blocks able to replace guanidinobenzoyl part of successful inhibitors. Physiological nature of flavonoids reveals biotechnological source of new trypsin inhibitors as antipancreatitis, anticancer and anti-inflammation drugs.
在寻找新型蛋白酶抑制剂的过程中,我们专注于多酚类化合物的筛选以及计算机辅助药物设计(CADD)研究。在本文中,我们报告了黄酮醇和黄酮作为胰蛋白酶抑制剂的计算机辅助药物设计,并附上筛选结果。已发现5,7-二羟基黄酮是一种有前景的胰蛋白酶/胰蛋白酶样酶抑制剂。由于失去了导致氢键相互作用的最佳几何结构,黄烷酮和异黄酮作为胰蛋白酶抑制剂的效果较差。观察到四种不同的相互作用模式,黄酮类化合物通过形成两个(芹菜素)或至少一个氢键以及其他重要的静电相互作用,在β-胰蛋白酶的S(1)区域得到稳定。槲皮素、杨梅素和桑色素已被证明是所测试的最佳胰蛋白酶抑制剂。一般来说,具有适当位置羟基基团和平面构象的黄酮类化合物是能够取代成功抑制剂中胍基苯甲酰部分的构建单元。黄酮类化合物的生理特性揭示了新型胰蛋白酶抑制剂作为抗胰腺炎、抗癌和抗炎药物的生物技术来源。